Non-culprit NIRS and IVUS findings and the association with MACCE
| n | MACCEn (%) | Multivariable HR 95% CI | P value | |
| LCBI ≥65 | 72 | 14 (19.4) | 3.08 (1.11 to 8.56) | 0.031 |
| MaxLCBI4mm ≥300 | 67 | 14 (20.9) | 4.32 (1.55 to 12.1) | 0.005 |
| MaxLCBI4mm ≥400 | 36 | 9 (25.0) | 3.67 (1.46 to 9.23) | 0.006 |
| MaxLCBI4mm ≥500 | 18 | 5 (27.8) | 2.98 (1.06 to 8.37) | 0.038 |
| MaxLCBI4mm ≥600 | 9 | 2 (22.2) | 1.87 (0.42 to 8.38) | 0.41 |
| MaxPB ≥65 | 23 | 3 (13.0) | 0.91 (0.26 to 3.17) | 0.86 |
| MaxPB ≥70 | 13 | 1 (7.70) | 0.61 (0.08 to 4.59) | 0.63 |
| MaxPB ≥75 | 8 | 1 (12.5) | 0.94 (0.12 to 7.00) | 0.94 |
| MaxPB ≥80 | 2 | 1 (50.0) | 3.27 (0.40 to 26.53) | 0.25 |
IVUS, intravascular ultrasound; LCBI, lipid core burden index; MACCE, major adverse cardiovascular and cerebrovascular events; MaxLCBI4mm, 4mm segment with maximum lipid core burden index; MaxPB, maximum plaque burden; NIRS, near-infrared spectroscopy.